{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:54:24Z","timestamp":1791053664337,"version":"4.1.0"},"reference-count":41,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma is among the most common and lethal cancers in humans. Hepatocellular carcinoma is commonly associated with physical or functional inactivation of the p53 tumor suppressor, high levels of chromosomal instability, and disease conditions causing chronic cycles of hepatocyte death and regeneration. Mounting evidence has implicated regeneration-induced telomere erosion as a potential mechanism fueling genome instability. In mouse models of hepatocellular carcinoma, telomere dysfunction has been shown to enhance initiation of hepatic neoplasias yet constrain full malignant progression of these neoplasms possibly due to activation of a p53-dependent checkpoint and\/or intolerable levels of genomic instability. Here, in a hepatocellular carcinoma\u2013prone model brought about through toxin-induced hepatocyte injury and regeneration, we sought to determine the cooperative interactions of germ line p53 mutation and telomere dysfunction [produced by telomerase reverse transcriptase (mTERT) gene knockout]. In the setting of intact telomeres, p53 mutation had no effect on hepatocarcinogenesis, whereas in the setting of telomere dysfunction, p53 mutation enabled advanced hepatocellular carcinoma disease. Notably, there was no evidence of deletion or mutation of the wild-type p53 allele in the late generation mTert\u2212\/\u2212p53+\/\u2212 mice, suggesting that reduced levels of p53 potently enable hepatocellular carcinoma progression in the setting of telomere dysfunction. Thus, this study supports a model that, in the face of chronic liver damage, attenuated p53 function and telomere-induced chromosomal instability play critical and cooperative roles in the progression of hepatocellular carcinoma. (Cancer Res 2006; 66(9): 4766-73)<\/jats:p>","DOI":"10.1158\/0008-5472.can-05-4608","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T15:18:51Z","timestamp":1146496731000},"page":"4766-4773","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Cooperative Interactions of p53 Mutation, Telomere Dysfunction, and Chronic Liver Damage in Hepatocellular Carcinoma Progression"],"prefix":"10.1158","volume":"66","author":[{"given":"Paraskevi A.","family":"Farazi","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology and"},{"name":"5Department of Genetics, Division of Medical Sciences, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Glickman","sequence":"additional","affiliation":[{"name":"3Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Horner","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"DePinho","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology and"},{"name":"2Center for Applied Cancer Science, Dana-Farber Cancer Institute; Departments of"},{"name":"4Medicine and Genetics, Brigham and Women's Hospital, Harvard Medical School; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,5,1]]},"reference":[{"key":"2022061622291153300_B1","unstructured":"American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society; 2005."},{"key":"2022061622291153300_B2","unstructured":"Anthony P. Pathology of the liver. London: Churchill Livingstone; 1996. p. 711\u201375."},{"key":"2022061622291153300_B3","doi-asserted-by":"crossref","unstructured":"Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet\u20082002; 31: 339\u201346.","DOI":"10.1038\/ng0802-339"},{"key":"2022061622291153300_B4","doi-asserted-by":"crossref","unstructured":"Badvie S. Hepatocellular carcinoma. Postgrad Med J\u20082000; 76: 4\u201311.","DOI":"10.1136\/pmj.76.891.4"},{"key":"2022061622291153300_B5","doi-asserted-by":"crossref","unstructured":"Bosch FX, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis\u20081999; 19: 271\u201385.","DOI":"10.1055\/s-2007-1007117"},{"key":"2022061622291153300_B6","doi-asserted-by":"crossref","unstructured":"Miura N, Horikawa I, Nishimoto A, et al. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet\u20081997; 93: 56\u201362.","DOI":"10.1016\/S0165-4608(96)00329-9"},{"key":"2022061622291153300_B7","doi-asserted-by":"crossref","unstructured":"Urabe Y, Nouso K, Higashi T, et al. Telomere length in human liver diseases. Liver\u20081996; 16: 293\u20137.","DOI":"10.1111\/j.1600-0676.1996.tb00748.x"},{"key":"2022061622291153300_B8","doi-asserted-by":"crossref","unstructured":"Kitada T, Seki S, Kawakita N, Kuroki T, Monna T. Telomere shortening in chronic liver diseases. Biochem Biophys Res Commun\u20081995; 211: 33\u20139.","DOI":"10.1006\/bbrc.1995.1774"},{"key":"2022061622291153300_B9","unstructured":"Rudolph KL. RAD, telomeres and telomerase in experimental liver cirrhosis. In: A.I.M., editor. The liver biology and pathobiology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 1001\u201311."},{"key":"2022061622291153300_B10","doi-asserted-by":"crossref","unstructured":"Wiemann SU, Satyanarayana A, Tsahuridu M, et al. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J\u20082002; 16: 935\u201342.","DOI":"10.1096\/fj.01-0977com"},{"key":"2022061622291153300_B11","doi-asserted-by":"crossref","unstructured":"Plentz RR, Caselitz M, Bleck JS, et al. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatoma. Hepatology\u20082004; 40: 80\u20136.","DOI":"10.1002\/hep.20271"},{"key":"2022061622291153300_B12","unstructured":"Farazi PA, Glickman J, Jiang S, Yu A, Rudolph KL, DePinho RA. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res\u20082003; 63: 5021\u20137."},{"key":"2022061622291153300_B13","doi-asserted-by":"crossref","unstructured":"Wiemann SU, Satyanarayana A, Buer J, Kamino K, Manns MP, Rudolph KL. Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage. Oncogene\u20082005; 24: 1501\u20139.","DOI":"10.1038\/sj.onc.1208308"},{"key":"2022061622291153300_B14","doi-asserted-by":"crossref","unstructured":"Greenberg RA, Chin L, Femino A, et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2\/3) cancer-prone mouse. Cell\u20081999; 97: 515\u201325.","DOI":"10.1016\/S0092-8674(00)80761-8"},{"key":"2022061622291153300_B15","doi-asserted-by":"crossref","unstructured":"Rudolph KL, Millard M, Bosenberg MW, DePinho RA. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet\u20082001; 28: 155\u20139.","DOI":"10.1038\/88871"},{"key":"2022061622291153300_B16","doi-asserted-by":"crossref","unstructured":"Gonzalez-Suarez E, Samper E, Flores JM, Blasco MA. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet\u20082000; 26: 114\u20137.","DOI":"10.1038\/79089"},{"key":"2022061622291153300_B17","doi-asserted-by":"crossref","unstructured":"Wong KK, Maser RS, Bachoo RM, et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature\u20082003; 421: 643\u20138.","DOI":"10.1038\/nature01385"},{"key":"2022061622291153300_B18","unstructured":"Qi L, Strong MA, Karim BO, Armanios M, Huso DL, Greider CW. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. Cancer Res\u20082003; 63: 8188\u201396."},{"key":"2022061622291153300_B19","doi-asserted-by":"crossref","unstructured":"Artandi SE, Chang S, Lee SL, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature\u20082000; 406: 641\u20135.","DOI":"10.1038\/35020592"},{"key":"2022061622291153300_B20","doi-asserted-by":"crossref","unstructured":"Chin L, Artandi SE, Shen Q, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell\u20081999; 97: 527\u201338.","DOI":"10.1016\/S0092-8674(00)80762-X"},{"key":"2022061622291153300_B21","doi-asserted-by":"crossref","unstructured":"Ueda H, Ullrich SJ, Gangemi JD, et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet\u20081995; 9: 41\u20137.","DOI":"10.1038\/ng0195-41"},{"key":"2022061622291153300_B22","doi-asserted-by":"crossref","unstructured":"Majumder M, Ghosh AK, Steele R, Ray R, Ray RB. Hepatitis C virus NS5A physically associates with p53 and regulates p21\/waf1 gene expression in a p53-dependent manner. J Virol\u20082001; 75: 1401\u20137.","DOI":"10.1128\/JVI.75.3.1401-1407.2001"},{"key":"2022061622291153300_B23","doi-asserted-by":"crossref","unstructured":"Nose H, Imazeki F, Ohto M, Omata M. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer\u20081993; 72: 355\u201360.","DOI":"10.1002\/1097-0142(19930715)72:2<355::AID-CNCR2820720208>3.0.CO;2-W"},{"key":"2022061622291153300_B24","doi-asserted-by":"crossref","unstructured":"Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature\u20081991; 350: 427\u20138.","DOI":"10.1038\/350427a0"},{"key":"2022061622291153300_B25","doi-asserted-by":"crossref","unstructured":"Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature\u20081991; 350: 429\u201331.","DOI":"10.1038\/350429a0"},{"key":"2022061622291153300_B26","doi-asserted-by":"crossref","unstructured":"Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet\u20081991; 338: 1356\u20139.","DOI":"10.1016\/0140-6736(91)92236-U"},{"key":"2022061622291153300_B27","doi-asserted-by":"crossref","unstructured":"Marrogi AJ, Khan MA, van Gijssel HE, et al. Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma. J Natl Cancer Inst\u20082001; 93: 1652\u20135.","DOI":"10.1093\/jnci\/93.21.1652"},{"key":"2022061622291153300_B28","doi-asserted-by":"crossref","unstructured":"Weber LW, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol\u20082003; 33: 105\u201336.","DOI":"10.1080\/713611034"},{"key":"2022061622291153300_B29","doi-asserted-by":"crossref","unstructured":"Blasco MA, Lee HW, Hande MP, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell\u20081997; 91: 25\u201334.","DOI":"10.1016\/S0092-8674(01)80006-4"},{"key":"2022061622291153300_B30","doi-asserted-by":"crossref","unstructured":"Herrera E, Samper E, Martin-Caballero J, Flores JM, Lee HW, Blasco MA. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J\u20081999; 18: 2950\u201360.","DOI":"10.1093\/emboj\/18.11.2950"},{"key":"2022061622291153300_B31","doi-asserted-by":"crossref","unstructured":"Jacks T, Remington L, Williams BO, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol\u20081994; 4: 1\u20137.","DOI":"10.1016\/S0960-9822(00)00002-6"},{"key":"2022061622291153300_B32","doi-asserted-by":"crossref","unstructured":"Lee HW, Blasco MA, Gottlieb GJ, Horner JW II, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature\u20081998; 392: 569\u201374.","DOI":"10.1038\/33345"},{"key":"2022061622291153300_B33","doi-asserted-by":"crossref","unstructured":"Erdmann N, Liu Y, Harrington L. Distinct dosage requirements for the maintenance of long and short telomeres in mTert heterozygous mice. Proc Natl Acad Sci U S A\u20082004; 101: 6080\u20135.","DOI":"10.1073\/pnas.0401580101"},{"key":"2022061622291153300_B34","doi-asserted-by":"crossref","unstructured":"Chang S, DePinho RA. Telomerase extracurricular activities. Proc Natl Acad Sci U S A\u20082002; 99: 12520\u20132.","DOI":"10.1073\/pnas.212514699"},{"key":"2022061622291153300_B35","doi-asserted-by":"crossref","unstructured":"Dong CK, Masutomi K, Hahn WC. Telomerase: regulation, function and transformation. Crit Rev Oncol Hematol\u20082005; 54: 85\u201393.","DOI":"10.1016\/j.critrevonc.2004.12.005"},{"key":"2022061622291153300_B36","doi-asserted-by":"crossref","unstructured":"Sarin KY, Cheung P, Gilison D, et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature\u20082005; 436: 1048\u201352.","DOI":"10.1038\/nature03836"},{"key":"2022061622291153300_B37","doi-asserted-by":"crossref","unstructured":"Flores I, Cayuela ML, Blasco MA. Effects of telomerase and telomere length on epidermal stem cell behavior. Science\u20082005; 309: 1253\u20136.","DOI":"10.1126\/science.1115025"},{"key":"2022061622291153300_B38","doi-asserted-by":"crossref","unstructured":"Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer\u20081954; 7: 462\u2013503.","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E"},{"key":"2022061622291153300_B39","doi-asserted-by":"crossref","unstructured":"Yumoto Y, Hanafusa T, Hada H, et al. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol\u20081995; 10: 179\u201385.","DOI":"10.1111\/j.1440-1746.1995.tb01075.x"},{"key":"2022061622291153300_B40","doi-asserted-by":"crossref","unstructured":"Bellamy CO, Clarke AR, Wyllie AH, Harrison DJ. p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage. FASEB J\u20081997; 11: 591\u20139.","DOI":"10.1096\/fasebj.11.7.9212083"},{"key":"2022061622291153300_B41","doi-asserted-by":"crossref","unstructured":"Masutomi K, Possemato R, Wong JM, et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc Natl Acad Sci U S A\u20082005; 102: 8222\u20137.","DOI":"10.1073\/pnas.0503095102"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/9\/4766\/2567214\/4766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/9\/4766\/2567214\/4766.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T22:02:17Z","timestamp":1655416937000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/9\/4766\/532863\/Cooperative-Interactions-of-p53-Mutation-Telomere"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2006,5,1]]},"published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-05-4608","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6495297","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6495297.v1","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22366803.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366803","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366800.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22366800","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}